News for 2007
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent agency funded by Canadian federal, provincial, and territorial governments to provide health care decision makers with credible, impartial advice and information about the effectiveness and efficiency of drugs and other health technologies. Unlike regulators who determine which technologies can be used in Canada, CADTH supports decision makers who are exploring what technologies should be used to achieve the best outcomes both on patient health and the health care system.
For details on how to contact CADTH, visit our Contact Us page.
Response to House of Commons Standing Committee on Health Report on the Common Drug Review: Canadian Agency for Drugs and Technologies in Health
December 12, 2007
OTTAWA — The Canadian Agency for Drugs and Technologies in Health (CADTH) today expressed its appreciation for the observations and recommendations made by the House of Commons Standing ...
CADTH launches Rx for Change – a publicly accessible interventions database on the effects of behaviour change strategies to help promote optimal prescribing and use of drugs
November 01, 2007
Ottawa – The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the launch of Rx for Change – a publicly accessible interventions database for health care ...
CADTH welcomes Health Council of Canada's report on Prescribing Behaviours
October 31, 2007
Ottawa – Safe and Sound, Optimizing Prescribing Behaviours, a new report from the Health Council of Canada, makes an important contribution to the on-going dialogue in Canada regarding the ...
Consultation on New CDR Transparency Initiatives
October 04, 2007
CADTH releases additional PPI intervention tools.
August 16, 2007
CDR Consultations – July 2007
June 29, 2007
PurposeThe Canadian Agency for Drugs and Technologies in Health invites all interested parties to provide feedback on three potential areas for change in the Procedure for Common Drug Review ...
CADTH Presentations to Standing Committee on Health
June 22, 2007
The House of Commons Standing Committee on Health is conducting a study to examine the status of and progress accomplished under the Common Drug Review (CDR). Representatives of CADTH appeared ...
Call for Nominations: CEDAC Professional Members
June 18, 2007
CADTH Participation in Standing Committee on Health Study of CDR
April 26, 2007
The House of Commons Standing Committee on Health is conducting a study to examine the status of and progress accomplished under the Common Drug Review (CDR).CADTH Submission to the Standing ...
CADTH Releases Intervention Tools aimed at influencing behaviour, regarding the prescribing and use of Proton Pump Inhibitors
April 25, 2007
OTTAWA — The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the release of Optimal Therapy Reports and Intervention Tools for the prescribing and use of ...
CADTH releases an Optimal Therapy Report on Proton Pump Inhibitors (PPIs) relating to the economic component of the COMPUS PPI Project.
April 13, 2007
CADTH Announces Expansion of Common Drug Review (CDR) Program
April 12, 2007
CDR to be expanded to new indications for old drugsThe Canadian Agency for Drugs and Technologies in Health (CADTH) today announced that it has received approval and funding from federal, ...
CADTH Announces Partners in Health Technology Assessment (PIHTA)
April 05, 2007
The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the selection of McMaster University’s Network of Excellence for the Assessment of Health Technologies ...
CADTH Awards 2007 HTA Capacity Building Grants
March 29, 2007
OTTAWA – The Canadian Agency for Drugs and Technologies in Health (CADTH) has awarded $475,000 in grants to support innovative projects in an effort to build capacity to carry out and apply ...
CADTH invites membership applications for the Health Technology Analysis Exchange (the Exchange)
March 27, 2007
The Health Technology Analysis Exchange (the Exchange) is a network of Health Technology Assessment producers established in accordance with Canada’s Health Technology Strategy (HTS 1.0). ...
CADTH Board Appoints Members to its New Canadian Optimal Medication Prescribing and Utilization Service Expert Review Committee (CERC)
February 28, 2007
OTTAWA - The Canadian Agency for Drugs and Technologies in Health’s (CADTH) Board of Directors today announced the appointment of the first Members to its newly established Canadian Optimal ...
Common Drug Review (CDR) - New Guidance for Oncology Submissions
February 22, 2007
CADTH invites stakeholders to review three draft economic reports as part of the COMPUS project on proton pump inhibitors (PPIs).
February 19, 2007
CADTH releases comprehensive HTA report on Point-of-Care Anticoagulation Monitoring Devices
February 07, 2007
CADTH invites membership applications for the Health Technology Analysis Exchange (the Exchange)
January 22, 2007
The Health Technology Analysis Exchange (the Exchange), a network of Health Technology Assessment producers, is being established in accordance with Canada’s Health Technology Strategy (HTS ...